In vitro safety "clinical trial" of the cardiac liability of drug polytherapy

Abstract Only a handful of US Food and Drug Administration (FDA) Emergency Use Authorizations exist for drug and biologic therapeutics that treat severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) infection. Potential therapeutics include repurposed drugs, some with cardiac liabilities. We...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Bérénice Charrez (Autor), Verena Charwat (Autor), Brian Siemons (Autor), Henrik Finsberg (Autor), Evan W. Miller (Autor), Andrew G. Edwards (Autor), Kevin E. Healy (Autor)
Format: Knjiga
Izdano: Wiley, 2021-05-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno